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Community and Clinical Epidemiology of Borderline Personality Disorder

William D. Ellison, PhD (corresponding author),1 Lia Rosenstein,2 Theresa A. Morgan, PhD,3
and Mark Zimmerman, MD4

Synopsis: Several studies of the prevalence of Borderline Personality Disorder (BPD) in
community and clinical settings have been carried out to date. Although results vary according to
sampling method and assessment method, median point prevalence of BPD is roughly 1%, with
higher or lower rates in certain community subpopulations. In clinical settings, BPD prevalence
is around 10-12% in outpatient psychiatric clinics and 20-22% among inpatient clinics. Further
research is needed to identify the prevalence and correlates of BPD in other clinical settings (e.g.,
primary care) and to investigate the impact of demographic variables on BPD prevalence.
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Key Points:
1. Point prevalence of BPD is roughly 1% in community settings.
2. Point prevalence of BPD in clinical settings is approximately 12% in outpatient
psychiatric clinics and 22% in inpatient psychiatric clinics.
3. Prevalence estimates of BPD depend greatly on the use of standardized, validated
methods for diagnosis; unstandardized or informal methods tend to underdiagnose BPD.
4. Prevalence of BPD varies according to certain demographic factors, such as age; more
research is needed into the demographic correlates of the disorder.
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Community and Clinical Epidemiology of Borderline Personality Disorder
This paper concerns the community and clinical epidemiology of Borderline Personality
Disorder (BPD) – its prevalence and characteristics in different community and treatment
settings and among different populations of individuals. We focus on a categorically defined
BPD entity, even if the exact definition varies across different diagnostic systems. Nevertheless,
there is compelling evidence that BPD is not a discrete condition that pertains to a class of
individuals (alongside another, complementary “healthy” class) but instead a dimensionally
distributed construct. Taxometric studies using different operationalizations of BPD and
conducted among different populations largely agree on this point,1-4 as does a comparison of the
fit of categorical and dimensional models of the latent structure of BPD.5 On the other hand, the
distribution of dimensionally defined borderline pathology is inadequately understood, and the
extant large-scale research has generally assumed a categorical model for BPD. Therefore, the
current review will focus on the epidemiology of the categorically defined BPD syndrome.
We also wish to highlight the importance of measurement for estimates of BPD
prevalence, as studies suggest that clinicians who do not use a dedicated assessment tool to
screen for, or diagnose, BPD tend to neglect the diagnosis. For example, Zimmerman & Mattia6
found that clinicians left to their own judgments diagnosed BPD in only 0.4% of outpatients,
compared to 14.4% by structured interview (a rate much more consistent with established
outpatient prevalence rates of BPD). Simply providing results of positive BPD diagnoses to
intake clinicians who had not used the interview themselves raised the diagnosis rate of BPD to
7%, suggesting the clinical utility of this information and the extent to which it can be neglected
in routine practice. Likewise, Comtois and Carmel7 compared BPD diagnoses produced by
routine clinical records and diagnoses from semi-structured research interviews among

outpatients in a public mental health service. They found that the interviews identified BPD in
15.1% of patients, whereas this diagnosis appeared in records 6.9% of the time. Even when
clinicians have the information necessary to make a BPD diagnosis, they often miss it. Hillman,
Stricker, & Zweig8 presented clinical vignettes describing individuals with major depression
only, or major depression with comorbid BPD, to 186 experienced psychologists. Only 14% of
respondents correctly made a BPD diagnosis when it was warranted.
Because of this discrepancy, when estimating community prevalence, we will focus on
epidemiological studies using a well-validated instrument for diagnosing BPD, although there
are some notable exceptions (described below) in which a validated instrument was not used but
its prevalence was estimated systematically at a later date. However, for clinical prevalence, we
will review both BPD prevalence estimates derived from a BPD-specific diagnostic measure and
those estimates derived from unstructured clinical assessment, and we will highlight several
additional studies that illustrate the importance of assessing for BPD in clinical settings.
Major Epidemiological Studies of BPD in the Community: United States
In the United States, several large epidemiological studies assessing BPD have been
conducted since the introduction of the DSM-III criteria for the disorder. Table 1 shows the
prevalence rates obtained from each of these studies. The first of these was the National Institute
of Mental Health’s Epidemiologic Catchment Area studies (ECA).9 The ECA studies collected
interviews from over 18,000 adult individuals across five catchment areas (New Haven,
Baltimore, St. Louis, central North Carolina, and Los Angeles), oversampling elderly, Black, and
Hispanic respondents. The NIMH Diagnostic Interview Schedule (DIS), a structured interview,
provided information about DSM-III disorders. However, the only personality disorder directly
assessed during this effort was antisocial PD. Despite the fact that BPD was not directly assessed

in the ECA studies themselves, three later studies attempted to derive BPD prevalence estimates
from ECA respondents. Swartz and colleagues10 used an empirically-derived algorithm relating
DIS symptoms to items from the Diagnostic Interview for Borderlines (DIB) to estimate the
prevalence of BPD in respondents from Wave II of the North Carolina site ECA study.
Separately, Samuels and colleagues11 followed 810 individuals from the Baltimore site who were
selected for “clinical reappraisal” by psychiatrists. The reappraisals used a semistructured
diagnostic instrument (the Standard Psychiatric Examination) that was not designed to diagnose
DSM-III personality disorders but rather general psychiatric symptoms, history, and functioning.
Information about BPD was later coded from these interviews. Finally, Samuels and colleagues12
reported on the prevalence of BPD among 742 individuals from the Baltimore ECA follow-up
survey,13 some of whom were among those examined by psychiatrists in the original ECA
clinical reappraisal. (Other respondents in Samuels et al.’s sample had a lifetime diagnosis of one
of six Axis I disorders at follow-up or were drawn randomly from the remaining ECA
respondents.) These individuals were diagnosed via the International Personality Disorder
Examination (IPDE).
The National Comorbidity Survey (NCS)14 provided an update of the ECA findings using
DSM-III-R criteria rather than those of DSM-III based on a stratified probability sample of
individuals in the continental United States rather than a set of discrete catchment areas.
Diagnoses were made using the World Health Organization’s Composite International
Diagnostic Interview (CIDI), which was based on the DIS and, like its predecessor, was fully
structured so that it could be used by lay interviewers. However, also like the ECA studies, the
battery used in the NCS only included antisocial PD from among the DSM-III-R personality
disorders, and no estimate of the prevalence of BPD in the NCS data has been made to date.

Crawford and colleagues15 reported on the prevalence of personality disorders among 644
adult residents of two upstate New York counties who were screened as part of the longitudinal
Children in the Community Study. Screening instruments were the Children in the CommunitySelf Report scales (CIC-SR) and the screener accompanying the Structured Clinical Interview for
DSM-IV Axis II (SCID-II), the SCID-II-PQ. The SCID-II was then administered in an
abbreviated fashion, omitting follow-up questions for those respondents who did not endorse
enough screening questions to warrant further inquiry. The stability of BPD in the study cohort,
as well as the cumulative prevalence for BPD from age 14 to age 33, are also available in
separate reports.16-18
The National Comorbidity Survey Replication (NCS-R)19 aimed to update the state of
knowledge about the epidemiology of mental disorders in the United States, using DSM-IV
criteria and an expanded list of assessed diagnoses. Importantly for BPD, the NCS-R assessed
personality disorders with the IPDE Screening Questionnaire and the IPDE itself for individuals
screening positive. 9282 adults received face-to-face interviews between 2001 and 2003.
Lenzenweger and colleagues20 reported on 12-month BPD prevalence in a probability subsample
of 214 respondents who received a “clinical reappraisal” interview. This subsample oversampled those who screened positive for one of the “core” clinical disorders but also included
some individuals who did not screen positive.
The National Epidemiological Survey on Alcohol and Related Conditions (NESARC) is
a community-based survey of adults from all 50 U.S. states and the District of Columbia. Faceto-face interviews were conducted with over forty thousand respondents by census workers with
minimal experience, who used an unvalidated Axis II diagnostic instrument, the Alcohol Use
Disorder and Associated Disabilities Interview Schedule-DSM-IV (AUDADIS-IV). Lifetime

BPD was assessed at Wave 2 of the study,21 which involved re-interviews of Wave 1 respondents
(34,653 of 43,093 Wave 1 respondents gave re-interviews, or 86.7%). Importantly, Grant and
colleagues gave a lifetime BPD diagnosis if sufficient BPD symptoms were present and at least
one symptom was associated with significant distress, impairment or dysfunction. This method
resulted in a lifetime prevalence estimate of 5.9%. However, some authors criticized this report
as being overly inclusive, and resulting in exaggerated PD prevalence estimates. Trull, Jahng,
Tomko, Wood and Sher22 revised the original NESARC scoring to require significant distress or
impairment be present to count each PD criterion individually, rather than cumulatively. The
authors then applied this revision to original NESARC algorithms, reporting a revised prevalence
rate of 2.7%.
Major Epidemiological Studies of BPD in non-US Communities
Several studies of BPD prevalence in communities outside the United States have also
been conducted. For example, Torgersen, Kringlen, and Cramer23 sampled individuals from the
National Register of Oslo, Norway. Personality disorders were assessed with the SIDP-R, which
was administered by nurses, medical students, and lay interviewers. Of the 3590 individuals
selected for inclusion, 2053 (57%) were interviewed.
Coid and colleagues24 reported results of a national survey of adult community members
in England, Wales, and Scotland. Initial screening for personality disorders was conducted under
the British National Survey of Psychiatric Morbidity, which used computer-assisted interviews.
Subsamples of the individuals screening positive in stage 1 for psychosis or a personality
disorder, as well as a subsample screening negative for all disorders, were offered follow-up
interviews. The stage 1 screening sample consisted of 8886 adults, of whom 628 individuals
completed a follow-up interview with the SCID-II.

Zanarini and colleagues25 reported on a survey of a cohort of 11-year-old community
participants in Bristol, England, who were part of the Avon Longitudinal Study of Parents and
Children (ALSPAC). These children were interviewed with the UK Childhood Interview for
DSM-IV Borderline Personality Disorder (UK-CI-BPD), which was based on the Diagnostic
Interview for DSM-IV Personality Disorders (DIPD-IV) but has modified language, content, and
structure to accommodate juvenile respondents. 6,330 children gave complete interviews.
Finally, ten Have and colleagues26 reported on BPD prevalence among adults in the
Netherlands, using a sample from the Netherlands Mental Health Survey and Incidence Study-2
(NEMESIS-2). Like the British National Survey of Psychiatric Morbidity,24 an initial stage of
computer-assisted interviews was conducted on a probability sample of individuals (n = 6646).
However, unlike that study, all respondents from this initial wave were approached for a followup interview including the eight BPD items from the IPDE, which were incorporated into the
CIDI. 5,303 individuals were included in the second-wave sample.
Community Subpopulations: BPD Prevalence in Adolescents and Older Adults
Despite evidence that BPD emerges in adolescence, it has typically been thought of as an
adult disorder. There has been resistance to diagnose it before the age of 18 on the basis that
personality has yet to solidify and that instability in identity and relationships is part of
normative development. However, due to the seriousness of the disorder and marked burden on
not only the individual but on the health care system, research efforts have shifted to focus on
early detection and prevention.27-28 These efforts parallel several recent findings that the BPD
diagnosis can indeed be made in adolescents with adequate reliability, stability, and validity.29-30
A systematic review31 found that rates of BPD in adolescent samples varied substantially
depending on study design and sample characteristics but overall tended to be higher than adult

samples. For example, Levy and colleagues32 found rates of BPD to be 43% in an adolescent
inpatient unit (mean age 15.5). Similar results were found by Grilo and colleagues,33 with BPD
prevalence rates of 49% in adolescent inpatients. Outside of inpatient settings, community and
clinical prevalence rates of BPD in adolescents tend to look similar to adult cohorts,20 with
estimates ranging from 0.9%34 to 3%16 in community samples and 11% in outpatients.35 Of note,
while BPD tends to be more prevalent in adult women than adult men, this gender split is not
apparent among adolescents.31
While research shows that some personality pathology is exacerbated across the lifespan,
BPD has been found to decrease and even remit as individuals age.36-37 A review of personality
disorder prevalence in younger and older age groups found rates of BPD to be significantly
lower in older adults as compared to younger adults.38 For example, one study found a
prevalence rate of 22% in a sample of young adults and a rate of 7% in an elderly sample.39
Another study found a BPD prevalence rate of 1% in a community sample of 200 adults over the
age of 60.40 Finally, a recent report of personality disorders in a community sample of
individuals aged 55 to 64 found a BPD prevalence rate of 0.4%.41 It has been hypothesized that
this decrease in prevalence is secondary to “burnout” in symptoms such as impulsivity or lost
social connections and therefore less interpersonal instability.36 A majority of the research on
prevalence rates is cross-sectional in design and more longitudinal studies extending into later
life are needed with regards to aging and prevalence of BPD.
Community Settings: University
An important community setting to consider when looking at diagnostic prevalence of
any psychiatric disorder is universities. Given the high risk for suicide and comorbid disorders
such as substance abuse, gaining estimates of BPD among university students is warranted. An

early estimate of BPD prevalence among college students comes from Lenzenweger and
colleagues,42 who applied a two-stage diagnostic procedure to a large sample of college students
in Ithaca, New York involving the IPDE-SQ and the IPDE. This study uncovered a point
prevalence of 1.3%, although follow-up studies highlighted striking differences in the trajectories
of PD symptoms in this cohort over a four-year period.43 This suggests that a BPD diagnosis may
not be stable among undergraduates, perhaps due to their relative youth or the fact that they are
generally high-functioning compared to other community populations. A recent meta-analysis
found that reported rates of BPD among college samples ranged from as low as 0.5% to as high
as 32.1%, likely reflecting the varying methodology among primary studies. Moreover, there was
an average lifetime prevalence rate of 9.7% in this population, and BPD prevalence was
significantly lower in Asian American college students than in other racial or ethnic groups. 44
Community Settings: Forensic
Highly prevalent in community and clinical populations, research indicates that rates of
BPD are higher still in forensic settings.45-48 Black and colleagues45 found a prevalence rate of
29.5% among a randomly selected sample of 220 individuals recently committed to prison.
Within this sample, the prevalence of BPD in female offenders was more than twice the
prevalence seen in male offenders (54.5% and 26.8% respectively). In a female inmate sample,
Jordan and colleagues47 found a similar overall BPD prevalence rate of 28%. In a small male
prison sample, Davison, Leese, and Taylor49 found a 45% rate of BPD using the SCID-II.
Overall, research suggests that prevalence of BPD in a forensic setting falls between about 25%
and 55%. Additional research is needed as to comorbidities and outcomes for individuals with
BPD in prison settings.
Clinical Epidemiology of BPD: Psychiatric Care Settings

In comparison to the general community population, BPD is highly prevalent in various
types of psychiatric settings.50 Table 2 summarizes prevalence estimates of BPD in studies of
psychiatric populations, focusing on samples that consist of consecutively admitted patients or
other naturalistic groups. The mean prevalence rate of BPD among inpatient samples across
these studies, weighted by sample size, is 22.4%, whereas the comparable mean for outpatient
samples is 11.8%. As above, we wish to highlight the discrepancy in prevalence estimates
derived from diagnostic practice “as usual” from those estimates derived through either a wellvalidated interview or a diagnostic process with deliberate attention to personality pathology. For
example, Kantojärvi and colleagues’ inpatient prevalence estimate of 5.6%, derived through
review of hospital records,51 is markedly lower than the inpatient average.
We also wish to highlight the Rhode Island Methods to Improve Diagnostic Assessment
and Services (MIDAS) project, an ongoing study of diagnostic methods that has amassed a
sample size of 3800 treatment-seeking outpatients.52 To date, this is by far the largest outpatient
sample to be diagnosed with semi-structured diagnostic interviews, and as such, it provides
perhaps the best single estimate of the outpatient prevalence of BPD. The most up-to-date
estimate of BPD prevalence from the MIDAS project found 390 individuals with BPD among
3674 individuals completing the SIDP-IV (10.6%).53
Clinical Settings: Primary Care
Whether an individual seeks consultation explicitly for their psychiatric symptoms or
whether screened for psychopathology by their physician during routine medical practice, the
gateway to psychiatric care for many individuals is through primary care providers. While there
is substantial information on the epidemiology of depression and anxiety in primary care
settings, little is known about the prevalence of BPD in such facilities. One problem is that

screening and assessment for BPD in primary care is lacking. For example, an examination of
computerized databases of primary care records in the Catalan Health Institute in Spain54 found a
prevalence of recorded BPD of only 0.017%, much lower than the prevalence in the general
population. This large discrepancy raises issues around screening for psychiatric disorders,
particularly BPD in primary care samples given the high rates of medical comorbidities in this
population. Likewise, a study in an urban primary care practice found that 42.9% of cases later
identified to have BPD had not been recognized as having psychiatric difficulties of any kind by
their primary care physicians.55 Given the increased risk of suicide and impaired psychosocial
functioning, the authors of this study argued that properly assessing BPD is vital to better
predicting and preventing potential ruptures in treatment and foreseeing issues in the patientphysician relationship. Further epidemiological studies are needed with regards to BPD in
primary care settings and behavioral medicine, with the ultimate goal of improving screening
practices to help triage patients to appropriate treatment.
Clinical Settings: Non-Psychiatric Specialty Care
Reviews of the prevalence of BPD in medical settings suggest that individuals with BPD
have been shown to be especially common among those presenting in medical settings with
alcohol and substance use disorders, multiple somatic complains, chronic pain, obesity, sexual
dysfunction (including sexual dissatisfaction and promiscuity), and trichotillomania.56-57 This
finding is essentially consistent with recent reviews documenting high levels of physical health
problems among individuals with BPD.58-59 It should be noted that the research basis for the
connections between BPD and these physical complaints varies considerably in both quantity
and quality; many primary studies used convenience samples rather than probability samples,

self-report measures or chart review rather than well-validated diagnostic interviews, or had
excessively small sample sizes.
Further reviews and primary studies have identified other specialty medical settings
where individuals with BPD can be found in large numbers, such as aesthetic plastic surgery
(especially to repair scars from deliberate self-injury)60 and bariatric surgery.61 Many of the
large-scale epidemiological studies reviewed above have also provided their own evidence that
Borderline Personality Disorder is associated with a wide array of physical health conditions.62-65
In short, there is suggestive to strong evidence to indicate that BPD is prevalent among
individuals seeking care for a wide variety of physical health complaints.
Given that personality pathology frequently co-occurs with alcohol and drug addiction,
high rates of BPD are seen in substance abuse clinics and programs. One study66 surveyed 320
patients enrolled in an outpatient addictions service targeting alcohol and opiate dependence and
found the prevalence rate of personality disorders to be 62.2%. While 0% of the sample met
criteria for schizotypal personality disorder and 13.8% qualified for an antisocial personality
disorder diagnosis, BPD had the highest prevalence of any specific personality disorder at 15%.
The authors also reviewed principal studies in the literature regarding the prevalence of
personality pathology in substance abusing samples and found that the rates of BPD varied
substantially between 3.2%67 and 65.1%.68
Summary and Areas in Need of Research
In sum, BPD is relatively common in the general population, with a point prevalence
around 1%. There are also subpopulations in which the prevalence is higher (e.g., incarcerated
individuals) or lower (e.g., elderly individuals) than this. The prevalence of BPD is substantially
higher in clinical settings, around 12% in the outpatient psychiatric population and 22% among

inpatients. Although there are no well-established prevalence rates in primary care, there is
reason to believe that BPD is quite common among individuals seeking medical care for a
variety of physical conditions.
There are some areas in which the epidemiology of BPD would particularly benefit from
additional research. For example, although extant studies of racial and ethnic differences in the
community prevalence of BPD do not show systematic differences,21,69 a recent review identified
racial differences in BPD prevalence in more specific settings.70 Research also suggests that
there may be differences among ethnic groups in the prevalence and extent of many indicators of
BPD, such as suicidality71-72 and deliberate self-harm.73 In addition, the association between
deliberate self-harm and borderline personality features differs among ethnic groups,74 and
African-American individuals with BPD have been shown to report more affective instability
and emotion dysregulation, but less suicidal behavior and deliberate self-harm, than White
American individuals with the disorder.75-76 Systematic studies of this topic are few, as are
studies of the impact of other demographic variables (e.g. socioeconomic status) on BPD
presentation and prevalence. Our knowledge of BPD’s epidemiology would be strengthened with
greater attention to these important issues.
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